Findings from St. Jude Children's Research Hospital demonstrate that virtual memory T cells, a specialized group of immune cells, provide nonspecific immunity for infants early in life. The work stems ...
Several infants treated with autologous ex vivo gene therapy for newly diagnosed X-linked severe combined immunodeficiency (X-SCID) in a phase I/II trial have developed fully functioning immune ...
X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural killer (NK) cell function, caused by mutations in ...
A gene therapy for a rare type of severe combined immunodeficiency (SCID) was safe and sufficiently restored T-cell immunity in an early trial, results from a phase I/II study showed. At a single ...
The cytokine receptor common gamma chain (γc) is shared among the receptors for interleukin (IL)-2, -4, -7, -9, -15, and plays a pivotal role in transmitting these cytokine signals. 1,2 Many of these ...
La Jolla, CA – New animal studies conducted at the Salk Institute for Biological Studies show that the only human gene therapy treatment to date considered to be largely successful, is, in fact, ...
A recent study conducted over seven years has streamlined the testing and diagnosis of newborns with severe combined immunodeficiency (SCID), facilitating early intervention ...
Early results from a study of newborn screening methods show that DNA analysis picks up many more preventable or treatable serious health conditions than standard newborn screening and is favored by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results